Inspiration Healthcare's Inspire rPAP granted a CE mark

The neonatal resuscitation device utilises technology that reduces the work of breathing imposed on an infant by traditional methods of ventilation. It is designed to deliver variable flow and pressure to a baby during resuscitation, and when this is not needed delivers nasal continuous positive airway pressure (nCPAP).

Inspiration Healthcare intends to launch the device in the UK and Europe, following an initial trial in Sweden, and will file for US registration to be able to market the

product globally.